CII News and Press, Blackrock Capital and Income Fund Inc. From 08/13/21

JEPI's trailing yield is 7.6% - it pays variable monthly distributions. JEPI buys S&P equities and also sells options and invests in ELNs for additional income. This article also details 6 other high-yield S&P-based income funds. For further details see: S&P ...

Time to revisit BlackRock Enhanced Capital & Income Fund that has been having a great year. This fund is overweight tech, but that hasn't seemed to disrupt the fund as much as it has the others. The fund's distribution yield is quite attractive, though it has come down conside...

When I get a question on a CEF or am looking at a new CEF, these are the first 5 things I will check. The five places I want to look first are; 1. Investment Policy, 2. Quick Review of Holdings, 3. Discount/Premium, 4. Performance, 5. Distributions. Once these items are checked, I...

The proverbial shot-across-the-bow came last week as the markets finally reacted to inflation fears as reflected in the sizzling CPI (Consumer Price Index) and PPI (Producer Price Index) numbers. The closure of the Colonial Pipeline due to a cyber attack didn't help either as gasoline...

Tying together our previous coverage of mistakes and misunderstandings related to taxes. We now dive into the benefits (or not beneficial) of the different tax breakdowns. Taxes can be as unique as investors' investment approach, meaning that they can be highly individualized for ...

In researching high-income opportunities for a Sustainable Income Portfolio, I looked into BlackRock's Option-Income Equity CEFs as a follow-up to an analysis of Eaton Vance's offerings. Of four funds, only two, BDJ and CII, merited close analysis. Two global funds were eliminated fro...

BlackRock Enhanced Capital & Income Fund (CII) declares $0.0875/share monthly dividend, in line with previous.Forward yield 5.78%Payable Feb. 26; for shareholders of record Feb. 16; ex-div Feb. 12.See CII Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: ...

Orexo AB (ORXOY) announces that it expects to file a New Drug Application for its Opioid overdose rescue drug OX124 with the US Food and Drug Administration by mid-2022.OX124 is expected to follow the FDA's standard submission and review timelines, as the FDA did not grant Fast...

The current environment of expensive equity valuations and high implied volatility is particularly attractive for covered call funds relative to outright equity exposure. We take a look at the different decision points for investors in the sector such as benchmark tilt, call overwrite...

CII had a strong 2020, thanks to its overweight to the tech sector. The fund can still offer attractive returns even at this level with its wide discount. CII currently pays a strong distribution yield of ~6%. For further details see: CII: Discounted And Attractive ~6% Y...